[AV-reentrant tachycardia and Wolff-Parkinson-White syndrome : Diagnosis and treatment].
[AV-reentrant tachycardia and Wolff-Parkinson-White syndrome : Diagnosis and treatment].
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Trier, DE · Author affiliation
Innere Medizin III, Krankenhaus der Barmherzigen Brüder Trier, Nordallee 1, 54290, Trier, Deutschland. F.Voss@bk-trier.de.Location evidence
Münster, DE · Author affiliation
Abteilung für Rhythmologie, Department für Kardiologie und Angiologie, Universitätsklinikum Münster, Münster, Deutschland.Location evidence
Coburg, DE · Author affiliation
Medizinische Klinik für Kardiologie, Angiologie und Pneumologie, Klinikum Coburg, Coburg, Deutschland.Location evidence
Munich, DE · Author affiliation
Medizinische Klinik und Poliklinik I, Universitätsklinikum München-Großhadern, München, Deutschland.Location evidence
Köln, DE · Author affiliation
Klinik III für Innere Medizin, Herzzentrum Uniklinik Köln, Köln, Deutschland.Location evidence
Leipzig, DE · Author affiliation
Abteilung für Rhythmologie, Herzzentrum Leipzig, Leipzig, Deutschland.Location evidence
Traunstein, DE · Author affiliation
Innere Medizin/Rhythmologie, Klinikum Traunstein, Traunstein, Deutschland.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
The AV-reentrant tachycardia (AVRT) is a supraventricular tachycardia with an incidence of 1-3/1000. The pathophysiological basis is an accessory atrioventricular pathway (AP). Patients with AVRT typically present with palpitations, an on-off characteristic, anxiety, dyspnea, and polyuria. This type of tachycardia may often be terminated by vagal maneuvers. Although the clinical presentation of AVRT is quite similar to AV-nodal reentrant tachycardias, the correct diagnosis is often facilitated by analyzing a standard 12-lead ECG at normal heart rate showing ventricular preexcitation. Curative catheter ablation of the AP represents the therapy of choice in symptomatic patients. This article is the fourth part of a series written to improve the professional education of young electrophysiologists. It explains pathophysiology, symptoms, and electrophysiological findings of an invasive EP study. It focusses on mapping and ablation of accessory pathways.